Gatifloxacin Patent Expiration
Gatifloxacin was first introduced by Allergan Inc
Gatifloxacin Patents
Given below is the list of patents protecting Gatifloxacin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Zymar |
US6333045 (Pediatric) | Aqueous liquid pharmaceutical composition comprised of gatifloxacin |
Feb 20, 2020
(Expired) | Allergan |
| Zymaxid |
US6333045 (Pediatric) | Aqueous liquid pharmaceutical composition comprised of gatifloxacin |
Feb 20, 2020
(Expired) | Abbvie |
| Zymar | US6333045 | Aqueous liquid pharmaceutical composition comprised of gatifloxacin |
Aug 20, 2019
(Expired) | Allergan |
| Zymaxid | US6333045 | Aqueous liquid pharmaceutical composition comprised of gatifloxacin |
Aug 20, 2019
(Expired) | Abbvie |
| Zymar |
US5880283 (Pediatric) | 8-alkoxyquinolonecarboxylic acid hydrate with excellent stability and process for producing the same |
Jun 05, 2016
(Expired) | Allergan |
| Zymaxid |
US5880283 (Pediatric) | 8-alkoxyquinolonecarboxylic acid hydrate with excellent stability and process for producing the same |
Jun 05, 2016
(Expired) | Abbvie |
| Zymar | US5880283 | 8-alkoxyquinolonecarboxylic acid hydrate with excellent stability and process for producing the same |
Dec 05, 2015
(Expired) | Allergan |
| Zymaxid | US5880283 | 8-alkoxyquinolonecarboxylic acid hydrate with excellent stability and process for producing the same |
Dec 05, 2015
(Expired) | Abbvie |
Gatifloxacin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List